Filing Details
Alkermes plc. (NASDAQ:ALKS) filed a Form 8-K with the Securities and Exchange Commission on August 12, 2026, disclosing a material event.
8k filedNASDAQ:ALKS
Alkermes plc. (ALKS) Reports Material Event to SEC
Alkermes plc. (NASDAQ:ALKS) filed a Form 8-K with the Securities and Exchange Commission on August 12, 2026, disclosing a material event.
At publication ·
What changed
Alkermes plc. (NASDAQ:ALKS) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Alkermes plc. filed a Form 8-K with the SEC on August 12, 2026, disclosing a material event that shareholders should be aware of, though the specific nature of the event is not detailed in this filing summary.
- Alkermes plc. trades at $50.28 per share with a market capitalization of $5.0 billion as a healthcare company.
- Material events reported on Form 8-K can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance, and investors can access all SEC filings through the EDGAR database.
Market Context
Alkermes plc.'s stock currently trades at $50.28 with a market capitalization of $5.0B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Alkermes plc.'s stock.
All SEC filings for Alkermes plc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ALKS Stock Page
Frequently Asked Questions
Where can I read ALKS's SEC filings?
Browse all filings on our ALKS SEC filings page.
What types of SEC filings does Alkermes plc. file?
Public companies like Alkermes plc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.